Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today? 2023/06/06 20:15:10 InvestorPlace
An upcoming event has gene editing stocks rising today. Editas Medicine (NASDAQ: EDIT ) has announced plans to present some important trial data via a live webinar next week on June 12 at 8 a.m. Eastern, the clinical-stage genome editing company will present the clinical data from its RUBY trial of EDIT-301 as a treatment for severe sickle cell disease. In a statement released by the company, Editas also noted that it will present “initial clinical data from the EDITHAL trial of EDIT-301 for the treatment of transfusion-dependent beta thalassemia.” News of this event has kept EDIT stock in the green all day, indicating that the market is reacting well. Does this mean that this positive momentum will continue as the webinar date draws closer? Let’s take a closer look at the event and assess what investors should be expecting. What’s Happening With Gene Editing Stocks Editas isn’t the only company benefitting from this announcement. Several other gene editing stocks are on the rise, one of which is outperforming EDIT.
Invitae to Present at the William Blair 43rd Annual Growth Stock Conference 2023/05/31 10:59:00 PR Newswire
SAN FRANCISCO, May 31, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president and chief executive officer, will present at the William Blair 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023, at 12:40 p.m….
Invitae CFO Wen resigning to pursue other opportunities, appoints Christine Gorjanc as interim CFO 2023/05/26 06:03:20 Seeking Alpha
Invitae (NVTA) notifies that Chief Financial Officer Yafei (Roxi) Wen is resigning to pursue other opportunities, effective June 30, 2023. A search for successor is underway. Ms
SNDL, Invitae among additions to Russell microcap; Inovio, Bionano among deletions 2023/05/24 17:33:04 Seeking Alpha
In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index
Invitae to appeal verdict in Natera patent case 2023/05/15 20:59:32 Seeking Alpha
Invitae (NVTA) said it will appeal a verdict in a patent case in a federal court in Delaware that found in favor of Natera (NTRA). Read more here.
Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023 2023/04/26 10:59:00 PR Newswire
SAN FRANCISCO, April 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30…
Why Shares of Invitae Soared on Friday 2023/04/22 01:52:11 The Motley Fool
Ark Innovation CEO Cathie Wood said the stock is undervalued.
Futures Slide In Risk-Off End To Volatile Week 2023/04/21 11:58:00 Zero Hedge
Futures Slide In Risk-Off End To Volatile Week US equity futures extended their recent weakness and traded near the week''s lows in early Friday trading as investors digested the latest corporate updates. Investors now await PMI data later today for further direction on the path for monetary policy. Contracts on the S&P 500 and the Nasdaq 100 drifted -0.2% lower as of 7:15 a.m. ET, as both indexes were set to end the week in negative territory, the Nasdaq underperforming slightly. Treasury yields edged higher, while the dollar advanced against other major currencies with a measure of its strength set for its first weekly gain in six weeks. Iron ore, gold and oil all decline, as the gains from the latest OPEC+ output cut are now all gone: so will OPEC cut again to reverse the slide in the one asset class that unlike stocks, everyone loves to short as a hedge for the coming recession? In premarket trading, Tesla edged higher after the electric-vehicle maker increased prices of its Model S and X vehicles in the United States just two days after cutting prices.
Invitae, CSX And Other Big Stocks Moving Higher In Friday''s Pre-Market Session 2023/04/21 10:39:05 Benzinga
U.S. stock futures traded mixed this morning. Here are some big stocks recording gained in today’s pre-market trading session. Mullen Automotive, Inc. (NASDAQ: MULN ) shares jumped 30.2% to $0.1103 in pre-market trading after dropping around 6% on Thursday. ContextLogic Inc. (NASDAQ: WISH ) gained 21% to $8.69 in pre-market trading after the company announced a $50 million buyback program. Atai Life Sciences N.V. (NASDAQ: ATAI ) gained 8.6% to $2.38 in pre-market trading after gaining around 7% on Thursday. Invitae Corporation (NYSE: … Full story available on Benzinga.com
Invitae Shares Surge On Cathie Wood Comments: Here''s What The Ark Invest CEO Said 2023/04/20 20:58:19 Benzinga
Invitae Corp (NYSE: NVTA ) shares are taking off … Full story available on Benzinga.com
Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases 2023/03/22 11:30:00 PR Newswire
The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield''s expertise in drug discovery to address high unmet needs among rare disease patients SAN FRANCISCO, March 22, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical…
Invitae, Epic team up to simplify access to genetic test results 2023/03/21 16:08:50 Seeking Alpha
Genetics company Invitae (NVTA) said it is collaborating with healthcare software company Epic to streamline genetic testing
Invitae Announces Partnership with Epic to Streamline Genetic Testing 2023/03/21 11:30:00 Invitae
Invitae (NYSE: NVTA), a leading medical genetics company, today announced its partnership with Epic, an industry-leading healthcare software company. Through Aura, Epic''s specialty diagnostics suite, Invitae will streamline interactions with provider organizations in the Epic community, making test result information available in providers'' usual workflows so that it''s easier to use genetic insights to inform treatment decisions. "Genetic testing can inform some of the most important care decisions in patients'' lives, and Invitae is making it more accessible to both patients and providers across the Epic community," said Dave Fuhrmann, senior vice president of research and development at Epic. "Aura will help them do so by further enabling precision medicine at many of the nation''s leading healthcare organizations." "Our use of Aura allows patients and providers to seamlessly access genetic testing that can help identify at-risk individuals, enhance early detection and better
Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology 2023/03/16 11:30:00 Kwhen Finance
Our Attention Has Been Attracted to Invitae Corporation (NYSE:NVTA) 2023/03/13 18:08:00 US Post News
Invitae Corporation (NVTA)’s stock has witnessed a price hike of 2.60% from the previous close with its current price standing at $1.45. Its current price is -84.24% under its 52-week high of $9.18 and 6.37% more than its 52-week low of $1.36. Based on the past 30-day period, the stock price is -39.32% below the […]